Similar results were observed in NSGS mice engrafted with human FLT3-ITD+ AML blasts compared with those engrafted with normal CB CD34+ cells (Fig. 1g, h; Additional file 1: Fig. S3, S7e and S10j). This evidence concerns the gene FLT3 and acute myeloid leukemia.